253 related articles for article (PubMed ID: 25446336)
1. Antiviral effect of cidofovir on parvovirus B19 replication.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of brincidofovir on parvovirus B19.
Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
[TBL] [Abstract][Full Text] [Related]
3. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.
Bonvicini F; Bua G; Manaresi E; Gallinella G
Virus Res; 2016 Jul; 220():47-51. PubMed ID: 27071853
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
Bonvicini F; Bua G; Conti I; Manaresi E; Gallinella G
Biochem Pharmacol; 2017 Jul; 136():32-39. PubMed ID: 28377277
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors.
Ning K; Roy A; Cheng F; Xu P; Kleiboeker S; Escalante CR; Wang J; Qiu J
J Virol; 2022 Jan; 96(2):e0132621. PubMed ID: 34669461
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 3-(Imidazo[2,1-
Conti I; Morigi R; Locatelli A; Rambaldi M; Bua G; Gallinella G; Leoni A
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875983
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.
Wong S; Zhi N; Filippone C; Keyvanfar K; Kajigaya S; Brown KE; Young NS
J Virol; 2008 Mar; 82(5):2470-6. PubMed ID: 18160440
[TBL] [Abstract][Full Text] [Related]
8. Advances in the Development of Antiviral Strategies against Parvovirus B19.
Manaresi E; Gallinella G
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323869
[TBL] [Abstract][Full Text] [Related]
9. Endonuclease Activity Inhibition of the NS1 Protein of Parvovirus B19 as a Novel Target for Antiviral Drug Development.
Xu P; Ganaie SS; Wang X; Wang Z; Kleiboeker S; Horton NC; Heier RF; Meyers MJ; Tavis JE; Qiu J
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530599
[TBL] [Abstract][Full Text] [Related]
10. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-mediated RNA interference for the inhibition of human parvovirus B19 replication.
Brandt MR; Kirste AG; Pozzuto T; Schubert S; Kandolf R; Fechner H; Bock CT; Kurreck J
Virus Res; 2013 Sep; 176(1-2):155-60. PubMed ID: 23770153
[TBL] [Abstract][Full Text] [Related]
12. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
Chen AY; Guan W; Lou S; Liu Z; Kleiboeker S; Qiu J
J Virol; 2010 Dec; 84(23):12385-96. PubMed ID: 20861249
[TBL] [Abstract][Full Text] [Related]
13. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.
Luo Y; Kleiboeker S; Deng X; Qiu J
J Virol; 2013 Dec; 87(23):12766-75. PubMed ID: 24049177
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Replication and Infection of Human Parvovirus B19.
Ganaie SS; Qiu J
Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
[TBL] [Abstract][Full Text] [Related]
15. No G-Quadruplex Structures in the DNA of Parvovirus B19: Experimental Evidence versus Bioinformatic Predictions.
Bua G; Tedesco D; Conti I; Reggiani A; Bartolini M; Gallinella G
Viruses; 2020 Aug; 12(9):. PubMed ID: 32854437
[TBL] [Abstract][Full Text] [Related]
16. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process.
Adamson-Small LA; Ignatovich IV; Laemmerhirt MG; Hobbs JA
Virus Res; 2014 Sep; 190():8-16. PubMed ID: 24998884
[TBL] [Abstract][Full Text] [Related]
17. A flow-FISH assay for the quantitative analysis of parvovirus B19 infected cells.
Manaresi E; Bua G; Bonvicini F; Gallinella G
J Virol Methods; 2015 Oct; 223():50-4. PubMed ID: 26231787
[TBL] [Abstract][Full Text] [Related]
18. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
Wolfisberg R; Ruprecht N; Kempf C; Ros C
J Virol Methods; 2013 Oct; 193(1):215-25. PubMed ID: 23764418
[TBL] [Abstract][Full Text] [Related]
19. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
Schmidt-Lucke C; Zobel T; Schrepfer S; Kuhl U; Wang D; Klingel K; Becher PM; Fechner H; Pozzuto T; Van Linthout S; Lassner D; Spillmann F; Escher F; Holinski S; Volk HD; Schultheiss HP; Tschope C
J Infect Dis; 2015 Oct; 212(7):1070-81. PubMed ID: 25805750
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.
Bua G; Manaresi E; Bonvicini F; Gallinella G
PLoS One; 2016; 11(2):e0148547. PubMed ID: 26845771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
